Publications by authors named "Sophie Bahlmann"
Article Synopsis
- Lung cancer is a serious health issue and is one of the most deadly types of cancer, with something called MIF possibly helping to understand it better.
- The study looked at blood samples from patients with different types of lung cancer to see if MIF could be used as a reliable marker for how well they respond to chemotherapy.
- Results showed that MIF levels didn’t help tell apart people who responded well to treatment from those who didn’t, but another marker called proGRP did show some promise in doing this.
